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Protein ubiquitination regulates protein stability and modulates the composition of signaling 22 
complexes. A20 is a negative regulator of inflammatory signaling, but the molecular mechanisms 23 
involved are ill-understood. Here, we generated Tnfaip3 gene-targeted A20 mutant mice bearing 24 
inactivating mutations in the zinc finger 7 (ZnF7) and ZnF4 ubiquitin-binding domains, revealing that 25 
binding to polyubiquitin is essential for A20 to suppress inflammatory disease. We demonstrate that 26 
a functional ZnF7 domain was required for recruiting A20 to the tumor necrosis factor receptor 1 27 
(TNFR1) signaling complex and to suppress inflammatory signaling and cell death. The combined 28 
inactivation of ZnF4 and ZnF7 phenocopied the postnatal lethality and severe multi-organ 29 
inflammation of A20-deficient mice. Conditional tissue-specific expression of mutant A20 further 30 
revealed the key role of ubiquitin-binding in myeloid and intestinal epithelial cells. Collectively, these 31 
results demonstrate that the anti-inflammatory and cytoprotective functions of A20 are largely 32 







A20, also referred to as Tumor Necrosis Factor alpha-induced protein 3 (TNFAIP3), has been 38 
implicated in diverse inflammatory diseases, and has been shown to act by repressing inflammatory 39 
NF-κB signaling and by promoting cell survival 1,2. A20 is thought to act as a ‘ubiquitin-editing’ 40 
enzyme that inhibits NF-κB signaling by modulating the ubiquitination status of specific signaling 41 
proteins through  the combined action of its deubiquitinase (DUB) activity and its E3 ubiquitin ligase 42 
activity that promotes K48-linked polyubiquitination and proteasomal degradation of its targets 43 
following tumor necrosis factor receptor 1 (TNFR1) activation 3. However, transgenic mouse strains 44 
with inactivating mutations in A20's DUB or E3 ligase domains are grossly normal and do not develop 45 
spontaneous disease 4-6, in sharp contrast to the systemic inflammatory and perinatal lethality seen 46 
in A20-deficient mice 7. These studies challenged the notion that A20 primarily acts via a ‘ubiquitin 47 
editing’ mechanism to suppress inflammation in vivo. Other studies suggest that the 7th zinc finger 48 
domain of A20 competes with the IκB kinase (IKK) adaptor protein  NEMO for binding to linear (M1) 49 
ubiquitin chains generated by the linear ubiquitin chain assembly complex (LUBAC) to repress TNF-50 
induced NF-κB signaling in vitro 8-10. However, the physiological role of A20’s ZnF7 domain is not 51 
known. 52 
To determine the physiological role of the ZnF7 domain of A20 in vivo, we generated Tnfaip3 gene-53 
targeted A20 mutant mice carrying two cysteine to alanine point mutations in the ZnF7 motif - C764A 54 
and C767A (hereafter referred to as A20ZnF7) (Extended Data Fig. 1a), which was previously shown to 55 
abrogate A20’s ability to bind to linear polyubiquitin chains 8,10,11. Homozygous A20ZnF7/ZnF7 knock-in 56 
mice, derived from interbred A20ZnF7/+ mice, were born with expected Mendelian frequency and did 57 
not display perinatal lethality (Extended Data Fig. 1b). This phenotype contrasts markedly with 58 
Tnfaip3–/– mice that, in our mouse facility, develop perinatal cachexia and die before weaning age 59 
(data not shown). However, all A20ZnF7/ZnF7 knock-in mice had severely reduced body weight (Fig. 1a, 60 
Extended Data Fig. 1c) and only rarely produced offspring. Macroscopic and histological examination 61 
of young A20ZnF7/ZnF7 mice revealed splenomegaly and lymphadenopathy (Extended Data Fig. 1d), paw 62 
swelling with absence of nails (Extended Data Fig. 1e), bone erosion (Extended Data Fig. 1f) and joint 63 
inflammation (Extended Data Fig. 1g), as previously shown 11, but also inflammation and immune cell 64 
infiltration in other tissues such as in the liver (Fig. 1b). Staining for cleaved caspase-3 revealed the 65 
presence of numerous apoptotic cells in A20ZnF7/ZnF7 livers but not in control livers (Fig. 1c, d), 66 
suggesting that A20ZnF7 expression sensitized hepatocytes to apoptosis. In agreement with the 67 
observed phenotype, A20ZnF7/ZnF7 knock-in mice had high serum concentrations of the inflammatory 68 
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cytokines TNF and interleukin 6 (IL-6, Fig. 1e). Flow cytometric analyses of spleen tissue from 20 69 
week-old mice revealed that A20ZnF7/ZnF7 knock-in mice had increased numbers of myeloid cells but 70 
reduced numbers of B cells, T cells and natural killer (NK) cells, demonstrating that A20’s ZnF7 71 
domain regulates immune homeostasis (Fig. 1f, Extended Data Fig. 2). Finally, in agreement with the 72 
increased TNF concentrations detected in their serum, A20ZnF7/ZnF7 myeloid cells displayed enhanced 73 
amounts of intracellular TNF (Fig. 1g). 74 
Cachexia and premature lethality in A20-deficient mice were shown to be promoted by MyD88-75 
mediated pro-inflammatory responses in the absence of A20 12. To address the role of MyD88-76 
dependent signaling in the inflammatory pathology of A20ZnF7/ZnF7 mice, these mice were crossed with 77 
Myd88–/– animals. As described recently 11, deletion of Myd88 in A20ZnF7/ZnF7 mice partly restored 78 
body weight (Extended Data Fig. 3a, b) and A20ZnF7/ZnF7 Myd88–/– mice were partially protected from 79 
developing spontaneous tissue inflammation, as shown by reduced inflammation in liver (Extended 80 
Data Fig. 3c) and absence of swollen toes and ankles (Extended Data Fig. 3d). Inflammatory cytokine 81 
concentrations in serum of A20ZnF7/ZnF7Myd88–/– mice were, however, elevated compared to control 82 
animals (Extended Data Fig. 3e). Together, these data demonstrate that MyD88-dependent 83 
mechanisms contribute to the local inflammatory pathology in the absence of ZnF7-dependent A20 84 
functions, while more systemic inflammation is unaffected. 85 
The role of A20 ZnF7 in regulating inflammation was further evaluated by examining the sensitivity of 86 
A20ZnF7/ZnF7 mice to TNF in vivo. Indeed, an important anti-inflammatory and cytoprotective role for 87 
A20 has been demonstrated in intestinal epithelial cells (IECs), and IEC-specific A20-deficient mice 88 
(A20IEC-KO) were previously shown to die from a challenge with a normally sublethal dose of TNF 13. In 89 
contrast to the control mice, which all survived and only showed a modest drop in body temperature 90 
in the first hours after TNF injection, A20ZnF7/ZnF7 mice displayed typical symptoms associated with 91 
TNF toxicity, including hypothermia and severe diarrhea, and all died within 3 h after TNF injection 92 
(Fig. 1h). A20ZnF7/ZnF7 mice displayed severe damage of the small intestine, showing extensive 93 
epithelial destruction and presence of numerous cleaved caspase-3 positive apoptotic IECs, in 94 
contrast to control littermates which maintained tissue integrity without showing epithelial cell 95 
apoptosis. Next to the damage of the intestinal tissue, massive apoptosis could be detected in liver 96 
tissue of A20ZnF7/ZnF7 mice upon exposure to TNF (Fig. 1i). Together, these data establish that A20’s 97 
ZnF7 motif is essential to restrict inflammatory responses in vivo. 98 
Consistent with the essential role of A20 as a negative feedback regulator of inducible NF-κB–99 
dependent gene expression, cultured mouse embryonic fibroblasts (MEFs) from A20ZnF7/ZnF7 knock-in 100 
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mice demonstrated increased TNF-induced NF-κB signaling, as reflected by earlier phosphorylation 101 
and sustained degradation of the NF-κB inhibitory molecule IκBα, and enhanced IL-6 production 102 
upon TNF stimulation compared to wild-type MEFs (Fig. 2a, b). Also cultured bone marrow-derived 103 
macrophages (BMDMs) from A20ZnF7/ZnF7 knock-in mice showed sustained degradation of IκBα and 104 
expressed and produced increased amounts of cytokines than control BMDMs in response to 105 
lipopolysaccharide (LPS) and TNF (Fig. 2c,d, Extended Data Fig. 4). In agreement with the reported 106 
role of A20 ZnF7 in binding M1 ubiquitin chains8-10, A20 recruitment to the TNFR1 complex was 107 
severely impaired upon stimulation of A20ZnF7/ZnF7 BMDMs with Flag-tagged TNF, similar to what is 108 
observed in A20-deficient BMDMs (Fig. 2e). Absence of A20 at the membrane-bound signaling 109 
complex (known as complex I) was also associated with reduced abundance of M1 chains in the 110 
TNFR1 signaling complex I (Fig. 2f), which is consistent with the reported role of A20 recruitment in 111 
protecting M1 chains from degradation9,14. Mutation of ZnF7 did not prevent the recruitment of 112 
RIPK1 and TRADD adaptor proteins to the TNFR1 complex (Fig. 2f). Destabilization of complex I by 113 
reduced M1 ubiquitination favored formation of the death-inducing complex II and activation of an 114 
apoptotic caspase cascade (Fig. 2g, h), as previously reported9,14.  115 
We previously demonstrated that mice with a myeloid-restricted deficiency in A20 spontaneously 116 
develop polyarthritis caused by myeloid cell necroptosis, NLRP3 inflammasome hyperactivation and 117 
IL-1 receptor (IL-1R) signaling 11,15,16. In agreement, A20ZnF7/ZnF7 BMDMs showed significantly 118 
enhanced NLRP3 inflammasome-mediated caspase-1 activation, pyroptosis and IL-1β and IL-18 119 
secretion upon stimulation with LPS and ATP (Fig. 2i-k). Together, these data illustrate the 120 
importance of the ZnF7 domain of A20 for preserving TNFR1 receptor complex integrity, and 121 
preventing cell death, inflammasome activation and inflammation. 122 
Although A20ZnF7/ZnF7 mice develop a spontaneous inflammatory phenotype, they do not fully 123 
recapitulate the phenotype of Tnfaip3–/– mice that develop severe multi-organ inflammation and 124 
cachexia and die in the first weeks after birth. This observation suggests that A20 exerts additional 125 
protective functions independent of its ZnF7 linear ubiquitin binding activity. In this respect, the ZnF4 126 
domain of A20 has been demonstrated to bind K63-linked polyubiquitin, and mutations in the A20 127 
ZnF4 ubiquitin-binding interface were shown to result in slightly impaired regulation of NF-κB 128 
signaling 4,17. Gene-targeted mice mutated in the A20 ZnF4 domain, however, did not develop 129 
spontaneous pathology4,6. To clarify the physiological role of A20’s ZnF4 domain in suppressing 130 
inflammation, we introduced two cysteine to alanine point mutations in the ZnF4 motif – C609A and 131 
C612A – of A20ZnF7 mice, generating mice with combined inactivation of the K63 polyubiquitin 132 
binding ZnF4 and M1 polyubiquitin binding ZnF7 domains (hereafter referred to as A20ZnF4ZnF7 mice) 133 
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(Extended Data Fig. 5a). Heterozygous A20ZnF4ZnF7/+ mice had a normal appearance without evidence 134 
of clinical pathology. In contrast, although A20ZnF4ZnF7/ZnF4ZnF7 mice were born at normal frequencies, 135 
they were severely runted and none of these animals survived past weaning age (Table 1, Extended 136 
data Fig. 5b). Gross and histological examination of tissues of 2-week-old A20ZnF4ZnF7/ZnF4ZnF7 mice 137 
revealed severe inflammation in multiple organs, including intestine, liver, and skin (Fig. 3a, b), and 138 
cleaved caspase 3-positive cells were detected in livers of A20ZnF4ZnF7/ZnF4ZnF7 mice, indicative of 139 
spontaneous liver cell apoptosis (Fig. 3c, d).  In addition, systemic inflammation in A20ZnF4ZnF7/ZnF4ZnF7 140 
mice was also evident from the detection of high serum concentrations of the inflammatory 141 
cytokines TNF and IL-6 (Fig. 3e).  142 
A20ZnF4ZnF7/ZnF4ZnF7 mice in a MyD88-deficient background did not die in the first postnatal weeks as is 143 
the case with A20ZnF4ZnF7/ZnF4ZnF7 mice (Extended Data Fig. 5c) and did not develop the severe tissue 144 
pathology as seen in MyD88-sufficient controls (Fig. 3f). However, these mice still failed to thrive, 145 
presented with severely reduced bodyweight and did not survive beyond 20 weeks of age (Fig 3g). 146 
Although 15 week-old A20ZnF4ZnF7/ZnF4ZnF7Myd88–/– did not display pronounced swelling of ankles and 147 
toes (Fig. 3h), histological examination still revealed inflammation in liver tissue of these mice (Fig. 148 
3i). These results demonstrate that MyD88 drives dysregulated homeostatic TLR signals in the 149 
absence of ZnF4 and ZnF7-dependent A20 functions in young mice, whereas MyD88-independent 150 
inflammatory signaling contributed to pathology at older age.  151 
Because A20ZnF4ZnF7/ZnF4ZnF7 mice are not viable, we next developed mice with a conditional ‘floxed’ 152 
allele of Tnfaip3, allowing tissue-specific expression of the ZnF4 and ZnF7 mutations through 153 
expression of a Cre recombinase (Extended data Fig. 6a). Mice homozygous for the loxP-flanked 154 
Tnfaip3ZnF4ZnF7 allele expressed normal amounts of A20 and developed normally (data not shown). 155 
General deletion of the loxP-flanked Tnfaip3ZnF4ZnF7 alleles through expression of a ubiquitous Cre 156 
recombinase triggered severe pathology and postnatal lethality, reminiscent of our observations in 157 
A20ZnF4ZnF7/ZnF4ZnF7 mice (Fig. 4a and Extended Data Fig. 6b). To test if myeloid-specific 158 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysM-Cre) also developed spontaneous arthritis as 159 
seen in myeloid-specific A20-deficient mice 11,15,16, we crossed loxP-flanked Tnfaip3ZnF4ZnF7 mice with 160 
LysM-Cre mice. Indeed, Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysM-Cre mice developed a progressive polyarthritis, 161 
characterized by immune cell infiltration, cartilage destruction indicated by decreased proteoglycan 162 
staining with toluidine blue, and bone erosion with increased osteoclast activity detected by tartrate-163 
resistant acid phosphatase (TRAP) staining (Fig. 4b-e and Extended Data Fig. 6c). Myeloid-specific 164 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice also had significantly higher serum concentrations of the inflammatory 165 
cytokines TNF and IL-6 compared to control littermate mice (Fig. 4f). In line with these in vivo 166 
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observations, cultured BMDMs from Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysM-Cre mice produced significantly more 167 
cytokines upon stimulation with LPS compared to control BMDMs (Fig. 4g), consistent with the role 168 
of A20 as a negative feedback regulator of inducible NF-κB–dependent gene expression.  169 
To investigate the consequence of mutant A20ZnF4ZnF7 expression in intestinal epithelial cells (IECs), we 170 
generated IEC-specific Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice by crossing loxP-flanked Tnfaip3ZnF4ZnF7 mice with 171 
villin-Cre mice (Tnfaip3ZnF4ZnF7/ZnF4ZnF7Vil1-Cre), and challenged these animals with a normally sublethal 172 
dose of TNF. As expected, control littermates all survived and only showed a modest drop in body 173 
temperature. In contrast, and as previously demonstrated in IEC-specific A20-deficient mice 13, IEC-174 
specific Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice displayed typical symptoms associated with TNF toxicity, including 175 
hypothermia and severe diarrhea, and all died between 5 and 10 h after injection due to the TNF-176 
induced apoptosis of A20 mutant IECs (Fig. 4h-j). Finally, IEC-specific Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice and 177 
control littermates were evaluated in the model of dextran sodium sulfate (DSS)-induced colitis. Mice 178 
were subjected to 1.5 % DSS in drinking water for 5 days and monitored daily for clinical pathology. 179 
Compared with control mice, IEC-Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice showed increased susceptibility to DSS-180 
induced colitis, similar to what had been shown with IEC-specific A20-deficient mice 13 (Extended 181 
Data Fig. 6d). In agreement, IEC-Tnfaip3ZnF4ZnF7/ZnF4ZnF7 mice showed more pronounced loss of 182 
intestinal barrier integrity after 5 days of DSS compared to the control group (Extended Data Fig. 6e). 183 
Unchallenged mice, however, did no show spontaneous barrier permeability (Extended Data Fig. 6e). 184 
In conclusion, we have demonstrated that A20 acts primarily as an ubiquitin-binding protein via both 185 
its ZnF4 and ZnF7 domains to suppress pro-inflammatory signaling. Upon TNFR1 and TLR4 activation, 186 
A20 is recruited to the receptor complexes through binding to linear ubiquitin chains via its ZnF7 in 187 
order to stabilize the respective signaling complexes and dampen downstream inflammatory 188 
signaling. We further show that A20’s anti-inflammatory activity also relies on its K63 ubiquitin-189 
binding ZnF4 domain, and mice lacking both functional ZnF4 and ZnF7 domains phenocopy A20-190 
deficient mice in that they die perinatally due to severe multi organ inflammation. Together, our 191 
observations suggest a mainly non-enzymatic role for A20 in suppressing inflammation by allowing its 192 
recruitment and the stabilization of ubiquitin chains in the receptor complex. However, A20’s DUB 193 
function may still be important in the downstream regulation of signaling. More studies, however, 194 
are needed to further investigate this.  195 
Multiple genetic studies over the past ten years have associated TNFAIP3 polymorphisms to diverse 196 
human inflammatory and autoimmune diseases2. These disease-associated variants are mostly 197 
located in upstream or downstream non-coding regions or in intronic regions of the TNFAIP3 gene, 198 
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which may affect the expression of A20 possibly by interfering with the function of cell- and 199 
activation-specific enhancers 18-21. Also loss-of-function mutations and deletions in TNFAIP3 have 200 
been identified, especially in patients with B cell lymphomas 22-24. The majority of these TNFAIP3 201 
mutations concern frameshift and premature stop codon mutations preventing the synthesis or 202 
compromising the ubiquitin-binding ability of the C-terminal ZnF7 domain 8,22-24. Furthermore, A20 203 
haploinsufficiency has recently been shown to cause a severe early-onset autoinflammatory disease, 204 
and peripheral blood monocytes isolated from these patients show severely reduced A20 expression 205 
25. Our findings presented here suggest that these mutations may cause a polyubiquitin-binding 206 
defect, that in these patients may be sufficient to affect homeostatic regulation of NF-κB signaling 207 
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Figure legends 296 
 297 
Figure 1. A20ZnF7/ZnF7 knock-in mice develop spontaneous inflammatory pathology and are 298 
sensitized to TNF induced toxicity. (a) Bodyweight of A20ZnF7/+ and A20ZnF7/ZnF7 mice in function of 299 
time. Each dot represents a biologically independent mouse (9 week-old mice: A20ZnF7/+, n=16; 300 
A20ZnF7/ZnF7, n=6; 12 week-old mice: A20ZnF7/+, n=15; A20ZnF7/ZnF7, n=7; 15week-old mice: A20ZnF7/+, 301 
n=11; A20ZnF7/ZnF7, n=7). Data are expressed as mean ± SEM. **** represents p<0.0001 (parametric 302 
two-way ANOVA between indicated genotypes). (b) Representative hematoxylin-eosin-stained 303 
sections of liver from 28-week-old control (A20+/+) and A20ZnF7/ZnF7 littermates. Scale bar, 200 µm and 304 
50 µm (insert). Picture representative for at least 5 biologically independent mice per group. (c-d) 305 
Immunohistochemistry for cleaved caspase 3 on liver sections from A20ZnF7/ZnF7 mice and control 306 
(A20+/+) littermates (c), and number of cleaved caspase 3-positive cells per mm2 (A20ZnF7/ZnF7, n=5 307 
biologically independent samples; A20+/+, n=4 biologically independent samples) (d). Pictures shown 308 
are representative for 5 biologically independent mice per group. Scale bar, 20 μm (insert, 10 µm) 309 
Data are expressed as mean ± SEM. * represents p=0.0159 (Two-sided non-parametric Mann 310 
Whitney test between indicated genotypes). (e) Levels of IL-6 and TNF in serum of control (A20+/+), 311 
A20ZnF7/+ and A20ZnF7/ZnF7 mice at the age between 15 and 30 weeks. Each dot represents a biologically 312 
independent mouse (IL-6: A20+/+, n=16; A20ZnF7/+, n=14; A20ZnF7/ZnF7, n=25; TNF: A20+/+, n=11; A20ZnF7/+, 313 
n=4; A20ZnF7/ZnF7, n=20).  Data are expressed as mean ± SEM. *, ** and **** represent p=0.0133, 314 
p=0.0014 and p<0.0001 respectively (parametric one-way ANOVA between indicated genotypes). (f) 315 
Absolute cell numbers of indicated immune cell populations in the spleens of A20+/+, A20ZnF7/+ and 316 
A20ZnF7/ZnF7 mice, as measured by flow cytometry. Each dot represents a biologically independent 317 
mouse (A20+/+, n=6; A20ZnF7/+, n=6; A20ZnF7/ZnF7, n=8). Data are expressed as mean ± SEM. *, **, *** 318 
represents p < 0.05, p < 0.01 and p < 0.001 (Two-sided non-parametric Mann-Whitney test between 319 
indicated genotypes). (g) Splenocytes isolated from A20+/+, A20ZnF7/+ and A20ZnF7/ZnF7 mice were 320 
incubated for 4 hours in the presence of protein transport inhibitors to assess intracellular TNF 321 
production by flow cytometry. Bar graphs represent percentage TNF that is produced within total 322 
macrophage (top) and Ly6Chi monocyte (bottom) populations. Each dot represents a biologically 323 
independent mouse (A20+/+, n=5; A20ZnF7/+, n=4; A20ZnF7/ZnF7, n=5). Data are expressed as mean ± SEM. 324 
* and ** represent p < 0.05 and p < 0.01 respectively (Two-sided non-parametric Mann-Whitney test 325 
between indicated genotypes). (h) Body temperature and survival of A20ZnF7/ZnF7 mice and control 326 
littermates injected with recombinant mTNF (i.p., 5 μg / 20 g of bodyweight), in function of time  327 
(A20+/+, n=7; A20ZnF7/+, n=5; A20ZnF7/ZnF7, n=5 mice). Data are expressed as mean ± SEM. p < ** and *** 328 
represent p<0.01, p<0.001, respectively (body temperature, REML analysis and survival, two-sided 329 
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mantel-cox test). (i) Cleaved caspase 3 staining on sections from small intestine (SI) and liver from 330 
control (A20+/+) and A20ZnF7/ZnF7 mice. Scale bar, 200 µm (liver) and 100 µm (SI). Pictures shown are 331 
representative for 5 biologically independent mice per group.  332 
 333 
Figure 2. ZnF7 is critical for A20-mediated suppression of inflammatory signaling and cell death. (a) 334 
Western blot analysis of whole cell lysates from A20+/+, A20ZnF7/ZnF7 and A20-/- MEF cells stimulated 335 
with TNF for the indicated time periods. Actin is shown as a loading control. Figure representative for 336 
3 independent experiments. (b) IL-6 secretion by control A20+/+, A20ZnF7/ZnF7 and A20-/- MEF cells, 337 
either or not stimulated with TNF for 4 h (A20+/+, n=3; A20ZnF7/ZnF7, n=3; A20-/-, n=3 independent cell 338 
cultures). **** represents p<0.0001 (parametric two-way ANOVA between indicated genotypes). 339 
Data are expressed as mean ± SEM. (c) Western blot analysis of whole cell lysates from A20+/+, 340 
A20ZnF7/ZnF7 and A20myel-KO BMDMs stimulated with LPS as indicated. β-tubulin is shown as a loading 341 
control. Figure representative for 3 independent experiments. (d) TNF and IL-6 secretion by BMDMs 342 
isolated from control A20+/+ (n=5), A20ZnF7/ZnF7(n=5) and A20myel-KO (n=5) mice, either or not stimulated 343 
with LPS for 6 h. *** and **** represent p<0.001 and p<0.0001 respectively (parametric two-way 344 
ANOVA between indicated genotypes). Data are expressed as mean ± SEM. (e) TNFR1 pulldown assay 345 
in BMDMs isolated from A20+/+, A20myel-KO and A20ZnF7/ZnF7 mice after stimulation with Flag-TNF (1 346 
µg/ml) for the indicated time periods, and immunoprecipitation of the TNFR1 complex with anti-Flag 347 
beads in presence of USP2 (24 µg/ml) and immunoblot for A20. Actin is shown as a loading control. 348 
Figure representative for 3 independent experiments. (f) TNFR1 pulldown on BMDMs isolated from 349 
A20+/+, A20myel-KO and A20ZnF7/ZnF7 mice stimulated with Flag-TNF (1 µg/ml) for the indicated time 350 
periods, and immunoprecipitation of the TNFR1 complex using anti-Flag beads and immunoblotted 351 
for A20, RIPK1, TRADD and M1. Figure representative for 3 independent experiments. (g) Cell death 352 
induction in A20+/+, A20ZnF7/ZnF7 and A20-/- MEFs stimulated with mouse TNF, in function of time as 353 
measured by SytoxGreen (SG+) positivity. Data are expressed as mean ± SEM, and representative of 3 354 
independent experiments (A20+/+, n=3; A20ZnF7/ZnF7, n=3; A20myel-KO, n=3 independent cell cultures). ** 355 
represents p<0.01 (RELM analysis) (h) Western blot analysis for expression of A20, full-length (FL) 356 
and cleaved (Cl) caspase-3 in A20+/+, A20ZnF7/ZnF7 and A20-/- MEFs stimulated with mouse TNF for the 357 
indicated time points. Actin is shown as loading control. Figure representative for 3 independent 358 
experiments (i) Immunoblot for procaspase-1 and cleaved caspase-1 (p20) in BMDMs from A20+/+, 359 
A20ZnF7/ZnF7 and A20myel-KO either or not stimulated with LPS and/or ATP. Actin is shown as loading 360 
control. Data are representative of three independent experiments. (j) IL1β and IL18 secretion by 361 
BMDMs isolated from A20+/+ (n=5), A20ZnF7/ZnF7 (n=5) and A20myel-KO (n=5) mice either or not stimulated 362 
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with LPS and ATP. Data represent the mean ± SEM.**, **** represent p<0.01 and p<0.0001, 363 
respectively (parametric two-way ANOVA between indicated genotypes). (k) Pyroptosis induction in 364 
BMDMs from A20+/+ (n=5), A20ZnF7/ZnF7 (n=5) and A20myel-KO (n=5) mice stimulated with LPS and ATP, as 365 
measured by Sytox Green (SG) uptake. Data are presented as mean ± SEM and are representative of 366 
three independent experiments. *** represents p<0.001 (RELM analysis). 367 
 368 
Figure 3. A20ZnF4ZnF7/ZnF4ZnF7 knock-in mice phenocopy A20 knockout mice. (a) Gross appearance of 369 
livers of 2-week old control A20+/+, A20ZnF4ZnF7/+ and A20ZnF4ZnF7/ZnF4ZnF7 mice. Note pale acellular regions 370 
in A20ZnF4ZnF7/ZnF4ZnF7 livers. Picture representative for 3 biologically independent mice. (b) 371 
Representative hematoxylin-eosin-stained sections from 2-week old control A20+/+, A20ZnF4ZnF7/+ and 372 
A20ZnF4ZnF7/ZnF4ZnF7 intestine (small intestine and colon), liver and skin. Note severe inflammation in all 373 
A20ZnF4ZnF7/ZnF4ZnF7 tissue sections. Scale bar, 100 μm. Pictures representative for 3 biologically 374 
independent mice. (c) Immunostaining for cleaved caspase 3 on liver sections from 2-week old 375 
control A20+/+ and A20ZnF4ZnF7/ZnF4ZnF7 mice. Pictures representative for 3 biologically independent 376 
mice. Scale bars, 50 µm (insert, 20 µm). (d) Quantification of cleaved caspase 3-positive cells in 377 
sections from the liver of 2-week old control A20+/+and A20ZnF4ZnF7/ZnF4ZnF7 mice. Number of cleaved 378 
caspase 3-positive cells per mm2 is shown (A20ZnF4ZnF7/ZnF4ZnF7, n= 5; A20+/+, n=3 mice)  Data are 379 
expressed as mean ± SEM. Each dot represents an individual mouse. *, p=0.036 (two-sided non-380 
parametric Mann Whitney test between indicated genotypes). (e) Levels of IL-6 and TNF in serum of 381 
control A20+/+, A20ZnF4ZnF7/+ and A20ZnF4ZnF7/ZnF4ZnF7 mice at the age of 2 weeks. Each dot represents a 382 
biologically independent mouse (A20+/+, n=19; A20ZnF4ZnF7/+, n=21; A20 ZnF4ZnF7/ ZnF4ZnF7, n=11).  Data are 383 
expressed as mean ± SEM. ****, p<0.0001 (parametric one-way ANOVA between indicated 384 
genotypes). (f) Representative hematoxylin-eosin-stained sections from liver and skin tissue of 2 385 
week-old A20ZnF4ZnF7/ZnF4ZnF7MyD88-/- mice and A20ZnF4ZnF7/ZnF4ZnF7MyD88+/- littermates. Scale bar, 100 386 
μm. Pictures representative for 3 biologically independent mice. (g) Bodyweight of 15-week old 387 
A20ZnF4ZnF7/ZnF4ZnF7MyD88-/- mice compared to control mice. Data are expressed as mean ± SEM. Each 388 
dot represents a biologically independent mouse (A20ZnF4ZnF7/+MyD88+/+, n=5; A20+/+MyD88-/-, n=11; 389 
A20ZnF4ZnF7/ZnF4ZnF7MyD88-/-, n=5). **** represents p<0.0001 (parametric one-way ANOVA between 390 
indicated genotypes). (h) Representative pictures of hindpaws of 15 week-old 391 
A20ZnF4ZnF7/ZnF4ZnF7MyD88-/- mice and control wild-type mice. (i) Representative hematoxylin-eosin-392 
stained liver sections from 15 week-old A20ZnF4ZnF7/ZnF4ZnF7MyD88-/- mice and control wild-type mice 393 
(scale bars, 50μm). Pictures representative for 3 biologically independent mice. Mark that 394 
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A20ZnF4ZnF7/ZnF4ZnF7 could not be used as control mice in Fig. 3g-i since these mice do not survive beyond 395 
the age of 3 weeks. 396 
 397 
Figure 4. Tissue-specific A20ZnF4ZnF7 expression phenocopies tissue-specific A20 deficiency. (a) Gross 398 
appearance of livers of 2-week old control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7CreDel+/+) and 399 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7CreDelTg/+ littermate mice. Note pale acellular regions in 400 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7CreDelTg/+ livers. (b) Representative picture of the hind paws of 32 week-old 401 
control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+) and Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+ littermate mice. (c) 402 
Biweekly clinical arthritis scores of the ankles of  control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+) and 403 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+ littermate mice (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+, n=6-15 mice per 404 
age, Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+, n=12-25 mice per age). Data are expressed as mean ± SEM. ** 405 
represents p=0.002 (REML analysis) (d) Histological images of H&E-stained ankle joints of mice with 406 
the indicated genotypes. Pictures representative for 5 biologicaly independent mice. (e) Graphs 407 
depicting histological scores for inflammation, bone erosion and cartilage destruction in mice with 408 
the indicated genotypes (28-33 weeks). Dots in the graphs indicate individual mice 409 
(Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+, n=10; Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+, n=21). Data are expressed as 410 
mean ± SEM. *, *** and **** represent p=0.0141, p=0.0003 and p<0.0001 respectively (Two-sided 411 
non-parametric Mann-Whitney test between indicated genotypes). (f) Levels of IL-6 and TNF in 412 
serum of control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+) and Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+ mice at the 413 
age of 30-40 weeks. Each dot represents a biologically independent mouse 414 
(Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+, n=11, Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+, n=27). Data are expressed as 415 
mean ± SEM. ** and **** represent p=0.0017 and p<0.0001 respectively (Two-sided non-parametric 416 
Mann-Whitney test between indicated genotypes). (g) TNF and IL-6 secretion by BMDMs isolated 417 
from control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCre+/+, n=6), Tnfaip3ZnF4ZnF7/ZnF4ZnF7LysMCreTg/+ (n=6) and 418 
A20myel-KO (n=6) littermate mice stimulated with LPS for the indicated time points. Data are expressed 419 
as mean ± SEM. **, *** and **** represent p<0.01, p<0.001 and p<0.0001 respectively (parametric 420 
two-way ANOVA between indicated genotypes at each time point). (h-j) 421 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7villinCreTg/+ (n=5) and control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7villinCre+/+, n=6) littermate 422 
mice were injected i.p. with 5 μg recombinant mouse TNF per 20 g of bodyweight. Body temperature 423 
(h, mean ± SEM, *** represents p<0.001, REML analysis) and survival (i, ** represents p=0.0018, 424 
Two-sided mantel-cox test) in function of time. (j) Representative cleaved caspase 3-specific staining 425 
on sections of small intestine of mice with the indicated genotypes 5 h past TNF injection. Scale bar, 426 






Table 1 : Birth and survival rates of control A20+/+, A20ZnF4ZnF7/+ and A20ZnF4ZnF7/ZnF4ZnF7 offspring from 431 
A20ZnF4ZnF7/+ x A20ZnF4ZnF7/+ breeding couples. 432 
 433 
Genotype Expected Observed (at birth) Observed (at weaning) 
A20+/+ 25 % (20) 18 18 
A20ZnF4ZnF7/+ 50 % (40) 46 46 
A20ZnF4ZnF7/ZnF4ZnF7 25 % (20) 16 0 







Mice. For the generation of gene-targeted A20-ZnF7 mice, Cas9 mRNA (Sigma) and protein (VIB 438 
Protein Service Facility, Ghent) together with a 151 bp single-stranded repair template (IDT) 439 
containing the homologous sequence around the mutations and two short guide RNAs (sgRNAs, 440 
Synthego) targeting the ZnF7 domain of the murine Tnfaip3 gene were microinjected into the 441 
pronucleus of zygotes obtained from C57BL/6J mice. Embryos were overnight incubated in KSOM 442 
medium and transferred the next day to foster mothers via oviduct transfer. sgRNA1: 5’-443 
AGCCATACATCTGCTTGAACTGG-3’; sgRNA2: 5’-ATTGCAGTAACCATTACACTTGG-3’; ssDNA 444 
oligonucleotides used as repair template containing two Cys-to-Ala point-mutations [TGC>GCC 445 
(C764A); TGC>GCT (C767A)] and two silent mutations [GCC>GCT (A758); TAC>TAT (Y768)] to avoid re-446 
editing after recombination: 5’-447 
GCCTGAAGAGCCCCCTAAACAGCGCTGCCGGGCCCCTGCTTGTGATCACTTTGGCAATGCTAAGTGTAATGGT448 
TACGCCAATGAGGCTTATCAGTTCAAGCAGATGTATGGCTAAGTGCGAACACATTGACAGGTCCAGCAAGAAG449 
GAGCC-3’. For the generation of A20-ZnF4/ZnF7 knockin mice, Cas9 protein together with a donor 450 
vector containing ~1 kb 5' and 3' homologous arms around the Cys-to-Ala mutations [TGC>GCC 451 
(C609A); TGT>GCT (C612A); TGC>GCC (C764A); TGC>GCC (C767A)] and two synonymous mutations 452 
[TCC>TCA (S577); TAC>TAT (Y768)], and two sgRNAs (sgRNA1: 5’- CTCCTGGAGTCCGTGCAGCCTGG-3’; 453 
sgRNA2: 5’-AGCCATACATCTGCTTGAACTGG-3’) targeting the ZnF4 and ZnF7 domain of the murine 454 
A20 gene were microinjected into the pronucleus of zygotes obtained from C57BL/6 mice. 455 
Conditional LoxP-flanked A20-ZnF4/ZnF7 knockin alleles were generated through homologous 456 
recombination in C57BL/6 ES cells. A neomycin resistance cassette flanked with RoxP sites was 457 
introduced after the last exon (exon 9) of the Tnfaip3 gene. Exons 6-9 and the neo cassette are 458 
flanked with LoxP sites. At the 3’ of the loxP flanked region we introduced a mutated exon 6-9 459 
containing the ZnF4 (C609A/C612A) and ZnF7 (C764A/C767A) mutations. In Tnfaip3ZnF4ZnF7 floxed 460 
mice the neomycine cassette has been removed by Dre-mediated recombination. Cre-mediated 461 
recombination excises the LoxP-flanked fragment containing the wild-type exons 6-9, resulting in the 462 
expression of the mutated exons 6-9. Mice with conditional LoxP-flanked Tnfaip3ZnF4ZnF7 alleles were 463 
crossed with the LysM-Cre26 or Vil1-Cre transgenic lines27. Myd88–/– mice were previously 464 
described28. Mice were housed in individually ventilated cages at the VIB Center for Inflammation 465 
Research, in a specific pathogen-free animal facility. All experiments on mice were conducted 466 
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according to institutional, national and European animal regulations. Animal protocols were 467 
approved by the ethics committee of Ghent University. 468 
 469 
Histological analysis of tissue sections. Liver, spleen, small intestine, colon, skin and joint sections 470 
were fixed in 4% paraformaldehyde for hematoxylin and eosin or immunostaining, or in Carnoy 471 
fixative (60% methanol, 30% chloroform, 10% glacial acetic acid) for Alcian Blue/Periodic Acid 472 
(AB/PAS) staining. Samples were dehydrated, embedded in paraffin, sectioned at 4 μm and examined 473 
by light microscopy.  Bright-field microscopy was done using an Axio Scan.Z1 (Zeiss). For joint 474 
pathology, formalin-fixed, EDTA-decalcified, paraffin-embedded mouse tissue specimens were 475 
sectioned and stained with hematoxylin and eosin, Toluidine Blue and TRAP [Leukocyte Acid 476 
Phosphatase Kit; Sigma-Aldrich]. H&E-, Toluidine Blue- and TRAP-stained joint sections were semi-477 
quantitatively and blindly evaluated for the following parameters: synovial inflammation/ 478 
hyperplasia (scale of 0–5), cartilage erosion (scale of 0–5), and bone loss (scale of 0–5) as described29. 479 
Isolation and immortalization of mouse embryonic fibroblasts. 12.5 dpc embryos from A20ZnF7/+ or 480 
A20ZnF4ZnF7/+ matings were isolated and mouse embryonic fibroblasts (MEFs) were prepared. MEFs 481 
were immortalized through serial passaging and frozen in liquid nitrogen. Confluent cells were 482 
stimulated with 20 ng/ml recombinant mouse TNF, after which cells were lysed for immunoblotting 483 
or quantitative real-time PCR.  484 
Isolation of bone marrow-derived macrophages. BMDMs were obtained from bone marrow cells 485 
flushed from mouse femurs and tibia with ice-cold sterile RPMI medium, and cultured in RPMI 1640 486 
supplemented with 40 ng/ml recombinant mouse M-CSF, 10% FCS, 1% penicillin/streptavidin and 487 
glutamine. Fresh M-CSF was added on day 3 and medium was refreshed on day 5. On day 7 cells 488 
were seeded and stimulated with 20 ng/ml ultrapure LPS (Escherichia coli 0111:B4 strain, InvivoGen) 489 
or 20 ng/ml ultrapure LPS (E. coli 0111:B4 strain, Invivogen) for 3 h followed by 5 mM ATP (Sigma-490 
Aldrich) for 20 min for NLRP3 activation. 491 
Cytokine detection. Cytokine concentrations in culture medium were determined by magnetic bead-492 
based multiplex assay using Luminex technology (Bio-Rad), IL-1β ELISA (Affymetrix eBioscience), IL-18 493 
ELISA (Biotechne - R & D Syst. Eur.), according to the manufacturers’ instructions. 494 
Immunoprecipitation studies. BMDMs were stimulated with human Flag–TNF (1 μg/ml) (VIB Protein 495 
Service Facility) as indicated. Cells were lysed in NP40 buffer (150 mM NaCl, 1% NP40, 10% glycerol 496 
and 10 mM Tris–HCl pH 8) and FLAG pulldown was performed using M2 beads (Sigma). The TNF-R1 497 
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signaling complex was eluted from beads using 3×FLAG peptide (Sigma) as described in the 498 
manufacturer’s instructions. For USP2 and PPase treatment, the beads were incubated with 499 
24 μg ml−1 USP2 (Enzo Life Sciences) and 8 U μl−1 λPPase (NEB) for 30 min at 37 °C before FLAG 500 
peptide elution. 501 
Cell death assay.  For cell death analysis in MEFs, cells were seeded the day before at 1 × 10 4 per 502 
well in triplicates in a 96-well plate. The next day, cells were stimulated with the indicated 503 
concentration of mTNF in the presence of 2.5 μM SytoxGreen (Invitrogen). SytoxGreen intensity was 504 
measured at intervals of one hour using a Fluostar Omega fluorescence plate reader, with an 505 
excitation filter of 485 nm and an emission filter of 520 nm, gains set at 1, 100, 20 flashes per well 506 
and orbital averaging with a diameter of 3 mm. For pyroptosis assay in BMDMs, cells were seeded 507 
the day before at 2.5 x 104 per well in triplicates in a 96-well plate. The next day, cells were 508 
stimulated with the indicated concentration of LPS and ATP in the presence of 0.25 μM SytoxGreen 509 
(Molecular probes). SytoxGreen intensity was measured at intervals of 5 min, for a total of 1 h, using 510 
a Incucyte device (EssenbioScience). Percentage of cell death was calculated as (induced 511 
fluorescence − background fluorescence)/(maximum fluorescence − background fluorescence) × 100. 512 
The maximal fluorescence is obtained by full permeabilization of the cells by using Triton X-100 at a 513 
final concentration of 0.1 %. All cell death data are presented as mean ± SEM of n (indicated in the 514 
figure) independent experiments, unless stated otherwise. 515 
Immunoblot analysis. Cells and tissue extracts were prepared in E1A lysis buffer (250 mM NaCl, 50 516 
mM Tris pH 7.4, 0.1% NP-40) containing a complete protease inhibitor cocktail (1:25) (Roche) and 517 
centrifuged for 10 min at 14,000 rpm in a microcentrifuge at 4°C or were directly lysed in 2× Laemlli 518 
buffer. For cleaved Caspase 1 immunoblotting, cell lysates and culture supernatants were incubated 519 
with cell lysis buffer (20 mM Tris HCl pH 7.4, 200 mM NaCl, 1% NP-40) and denatured in Laemmli 520 
buffer. Supernatants were separated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred 521 
to nitrocellulose and immunodetected with anti-IκBα (Santa Cruz Biotechnology, Inc., sc-371), anti-522 
phospho-IκBα (Cell Signaling, CST9246), anti-A20 (Santa Cruz Biotechnology, Inc., sc-166692), anti-523 
p38 (Cell Signaling, CST9212), anti-phospho-p38 (Cell Signaling, CST9215), anti-Caspase3 (Cell 524 
Signaling, CST9662), anti-SAPK/JNK (Cell Signaling, CST9252), anti-phospho-SAPK/JNK (Cell Signaling, 525 
CST4668), anti-caspase-1 (Adipogen, AG-20B-0042), anti-β-tubulin (Sigma-Aldrich, T4026) and anti-β-526 
actin (Santa Cruz Biotechnology, Inc., sc-47778) antibodies. 527 
In vivo TNF toxicity. Mice were injected i.p. with a sublethal dose of mouse TNF (5 μg mouse TNF/20 528 
g mouse). E. coli-expressed recombinant mTNF was produced and purified to homogeneity in our 529 
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laboratory, and endotoxin levels did not exceed 1 ng/mg protein. Body temperature and survival 530 
were monitored every hour. In a separate experiment, mice were euthanized after 2 h (A20ZnF7) or 5 531 
h (Tnfaip3ZnF4ZnF7/ZnF4ZnF7Vil1-Cre) for histological analysis.  532 
Induction of DSS-induced colitis and clinical score. Acute colitis was induced by addition of 1.5 % 533 
dextran sodium sulphate (DSS, 36–50 kDa; MP Biomedicals) to the drinking water for 5 days. Body 534 
weight, stool consistency and fecal blood were determined daily. Fecal blood was determined using 535 
Hemoccult SENSA (Beckman Coulter) analysis. The baseline clinical score was determined on day 0. In 536 
brief, no weight loss was scored as 0, weight loss of 1–5 % from baseline as 1, 5–10 % as 2, 10–20 % 537 
as 3, and >20 % as 4. For bleeding, a score of 0 was assigned for no blood, 2 for positive hemoccult, 538 
and 4 for gross bleeding. For stool consistency, a score of 0 was assigned for well-formed pellets, 539 
pasty and semi-formed stools were scored as 2, and liquid stools as 4. The average of these 3 scores 540 
was used as total clinical score, ranging from 0 (healthy) to 4 (maximal colitis). 541 
FITC–dextran intestinal permeability assay. Intestinal permeability was assessed by oral gavage of 542 
FITC–dextran (MW: 3000-5000, Sigma). Mice were administered 12 mg of FITC-dextran per 20 g body 543 
weight in sterile PBS by oral gavage. After 4 h, blood was collected from the facial vein, and FITC–544 
dextran concentrations were measured in 50 μl of serum by fluorometry (485 nm). Mice were 545 
anesthetized during blood collection. Serial dilutions of FITC–dextran in PBS were used each time to 546 
generate a standard curve and serum from PBS-gavaged mice was used as blanks. 547 
Clinical scoring for arthritis development. The severity of arthritis was assessed using a visual scoring 548 
system. Mice were scored every two weeks for development of peripheral arthritis. A score ranging 549 
from 0 to 3 was assigned to each paw, with 0 being normal, 0.5 being swelling of one or more toes, 1 550 
being mild swelling of the wrist and/or ankle or carpus and/or tarsus, 2 being moderate swelling of 551 
the wrist and/or ankle or carpus and/or tarsus or mild swelling of both, and 3 being severe swelling 552 
of the entire paw. 553 
Quantitative real-time PCR. Total RNA was isolated using TRIzol reagent (Invitrogen) and Aurum 554 
Total RNA Isolation Mini Kit (Biorad), according to manufacturer’s instructions. Synthesis of cDNA 555 
was performed using iScript cDNA synthesis kit (BioRad) according to the manufacturer’s 556 
instructions. cDNA was amplified on quantitative PCR in a total volume of 5 μl with SensiFAST SYBR® 557 
No-ROX Kit (Bioline) and specific primers on a LightCycler 480 (Roche). The reactions were performed 558 
in triplicates. The following mouse-specific primers were used: Rpl13a forward, 5’-559 
CCTGCTGCTCTCAAGGTT-3’; Rpl13a reverse, 5‘-TGGTTGTCACTGCCTGGTACTT-3’; Rpl13a forward, 5’-560 
AGTGTTGGATACAGGCCAGAC-3’; Rpl13a reverse, 5’-CGTGATTCAAATCCCTGAAGT-3’; Tnf forward, 5’-561 
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ACCCTGGTATGAGCCCATATAC-3’; Tnf reverse, 5’-ACACCCATTCCCTTCACAGAG-3’; Il1b forward, 5’-562 
CACCTCACAAGCAGAGCACAAG-3’; Il1b reverse, 5’-GCATTAGAAACAGTCCAGCCCATAC-3’; Il6 forward, 563 
5’-GAGGATACCACTCCCAACAGACC-3’; Il6 reverse, 5’-AAGTGCATCATCGTTGTTCATACA-3’; Il18 564 
forward, 5’-CAGGCCTGACATCTTCTGCAA-3’; Il18 reverse, 5’-TCTGACATGGCAGCCATTGT-3’. 565 
Flow cytometry. Spleens were isolated and processed to a single-cell suspension. 5 × 106 splenocytes 566 
were stained with a combination of the following fluorochrome- or biotin-labeled monoclonal 567 
antibodies: CD3 (Thermo Fisher Scientific, 145-2c11 or 17A2), CD4 (BD Biosciences, GK1.5), CD8 568 
(Thermo Fisher Scientific, 53-6.7), CD11b (BD Biosciences, M1/70), CD11c (Thermo Fisher Scientific, 569 
N418), CD16/32 (Bioceros, 2.4G2), CD19 (Thermo Fisher Scientific, 1D3), CD62L (BD Biosciences, MEL-570 
14), CD64 (BioLegend, X54-5/7.1), F4/80 (BioLegend, BM8), Ly6C (Thermo Fisher Scientific, HK1.4), 571 
Ly6G (BD Biosciences, 1A8), NK1.1 (BD Biosciences, PK136), SiglecF (BD Biosciences, E50-2440), and 572 
TNF (BD Biosciences, MP6-XT22). Intracellular staining for TNF was performed with the Foxp3 kit 573 
(eBioscience, 00-5523-00). Cell viability was measured using an eFluor 506 (eBioscience, 65-0866-18) 574 
or eFluor780 (eBioscience, 65-0865-14) fixable viability dye. Absolute cell counts were determined by 575 
use of 123 count ebeads (eBioscience, 01-1234-42).  Samples were measured on a FACS Fortessa 5 576 
laser or BD FACSymphony (BD Biosciences) and data were analyzed using FlowJo. 577 
Ex vivo cytokine production. To assess intracellular TNF production, 5 × 106 splenocytes were 578 
cultured in DMEM (Gibco) supplemented with 10% FCS (Bodinco) in the presence of monensin 579 
(420701, BioLegend) and brefeldinA (420601, Biolegend) and incubated 3.5 h at 37°C. 580 
Statistics. Results are expressed as the mean ± SEM or mean ± SD, as indicated in figure legend. 581 
Statistical significance between experimental groups was assessed using a nonparametric Mann–582 
Whitney U-statistical test. Statistical significance between multiple groups was assessed using either 583 
one- or two-way ANOVA with Tukey correction for multiple comparison. Comparison of 2 or more 584 
groups over time was analysed as longitudinal data (repeated measurements over time) using the 585 
residual maximum likelihood (REML) as implemented in Genstat v1930. Briefly, a linear mixed model 586 
(random terms underlined) of the form response = μ + genotype + time + genotype.time + 587 
subject.time was fitted to the longitudinal data. The term subject.time represents the residual error 588 
term with dependent errors because the repeated measurements are taken repeatedly from the 589 
same subjects, causing correlations among observations. Times of measurement were set as equally 590 
spaced, and the best correlation model was selected based on the Aikake Information Coefficient 591 
(AIC). Significance of genotype effects over time (i.e. genotype.time) and changes in differences 592 
between genotype effects over time were assessed by an approximate F-test, of which the 593 
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denominator degrees of freedom were calculated using algebraic derivatives as implemented in 594 
Genstat v1930. 595 
 596 
Data availability statement. All data supporting the findings of this study are available from the 597 
corresponding author on reasonable request. 598 
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Extended Data Figure legends 
 
Extended Data Figure 1. A20ZnF7 knock-in mice. (a) Schematic depiction of the A20/Tnfaip3 locus 
indicating the sequence of the single stranded oligonucleotide used for mutating the ZnF7 domain 
that was introduced by pronuclear injection into mouse zygotes, and sequencing result of the wild-
type (WT) and of the targeted ZnF7 knock-in allele. Boxes indicate exons 3 to 9 (E3–E9). (b) Birth and 
survival rates of control (A20+/+), A20ZnF7/+ and A20ZnF7/ZnF7 offspring from A20ZnF7/+ x A20ZnF7/+ breeding 
couples. (c) Gross appearance of A20ZnF7/+ and A20ZnF7/ZnF7 mice. (d) Representative pictures of spleen 
and inguinal lymph nodes from 28-week-old control (A20+/+) and A20ZnF7/ZnF7 littermate mice. (e) 
Representative pictures of hindpaws of 15-week-old control (A20+/+) and A20ZnF7/ZnF7 littermates, 
showing extensive swelling of the toes of the A20ZnF7/ZnF7 mice. (f) Representative micro-CT pictures 
of hindpaws (left) and knees (right) of 28-week-old control (A20+/+) and A20ZnF7/ZnF7 littermates. (g) 
Representative hematoxylin-eosin-stained histological images of ankle joints (left) and toes (right) 
from 28-week-old control (A20+/+) and A20ZnF7/ZnF7 littermates. Scale bar, 500 µm.   
 
Extended Data Figure 2. FACS immunophenotyping of spleen of control and A20ZnF7 mice. (a-c) 
General gating strategy as applied for immune cell populations described in Figure 1g. (a) 
Lymphocytes, singlets, live, CD3-CD19+ (B cells), CD3+CD19- (T cells) and CD3-CD19- NK1.1+ (NK cells); 
(b) non-debris, singlets, live, lineage- (CD3-CD19-NK1.1-), F4/80+, CD64+ and autofluorescent; (c) non-
debris, singlets, live, lineage-, Ly6G+CD11b+ (neutrophils) and Ly6G-SiglecF-Ly6ChiCD11b+ (monocytes). 
FSC: forward scatter, SSC: side scatter, A: Area, H: height, W: width, L/D: live/dead. (d-f) Bar graphs 
representing absolute numbers of total (left) and naive (right) CD4 T cells (d), total (left) and naive 
(right) CD8 T cells (e) and yd T cells (f) as measured by flow cytometry in the spleens of A20+/+, 
A20ZnF/+ and A20ZnF7/ZnF7 animals. Data are expressed as mean ± SEM. *, ** represent p < 0.05 and p < 
0.01 (Two-sided non-parametric Mann-Whitney test between indicated genotypes).   
 
Extended Data Figure 3. MyD88-dependent mechanisms contribute to the local inflammatory 
pathology in A20ZnF7 mice (a-b) Gross appearance (a) and bodyweight (b) of of 10 week-old  
A20ZnF7/+MyD88+/-, A20ZnF7/ZnF7MyD88+/- and A20ZnF7/ZnF7 MyD88-/-  mice. Each dot represents a 
biologically independent mouse (A20ZnF7/+MyD88+/-, n=9; A20ZnF7/ZnF7MyD88+/+, n=13 and A20ZnF7/ZnF7 
MyD88-/-, n=6). Data are expressed as mean ± SEM. * and **** represent p<0.05 and p<0.0001, 
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respectively (parametric two-way ANOVA between indicated genotypes). (c) Representative 
hematoxylin-eosin-stained sections of liver from 18-week-old A20ZnF7/ZnF7MyD88+/+ and 
A20ZnF7/ZnF7MyD88-/- littermates. Scale bar, 50 μm. Picture representative for 3 biologically 
independent mice. (d) Representative pictures of hindpaws of 10-week-old A20ZnF7/ZnF7MyD88+/+ and 
A20ZnF7/ZnF7MyD88-/- littermates. Pictures representative for 3 biologically independent mice (e) Levels 
of IL-6 and TNF in serum of A20+/+MyD88+/+, A20+/+MyD88-/-, A20ZnF7/ZnF7MyD88+/+  and  
A20ZnF7/ZnF7MyD88-/- mice. Each dot represents a biologically independent mouse (A20+/+MyD88+/+, 
n=9; A20+/+MyD88-/-, n=3; A20ZnF7/ZnF7MyD88+/+, n=13  and  A20ZnF7/ZnF7MyD88-/-, n=6). Data are 
expressed as mean ± SEM. *, ** represent p<0.05 and p=0.0033 respectively (parametric one-way 
ANOVA between indicated genotypes). 
 
Extended Data Figure 4. ZnF7 is critical for A20-mediated suppression of inflammatory signaling. 
Western blot analysis of whole cell lysates from A20+/+, A20ZnF7/ZnF7 and A20myel-KO BMDMs stimulated 
with TNF as indicated. β-tubulin is shown as a loading control. Figure representative for 3 
independent experiments. 
 
Extended Data Figure 5. A20ZnF4ZnF7 knock-in mice. (a) Schematic depiction of the A20/Tnfaip3 locus 
indicating the position of ZnF4 and ZnF7 mutations. Boxes indicate exons 3 to 9 (E3–E9). Sequences 
of the donor vector, containing ~1kb 5' and 3' homologous arms around the Cys-to-Ala mutations 
used for mutating the ZnF4 and ZnF7 domains, that were introduced by pronuclear injection into 
mouse zygotes. Sequencing result of the wild-type (WT) allele and of the targeted ZnF4 and ZnF7 
knock-in alleles. (b) Gross appearance of 2-week old control (A20+/+), A20ZnF4ZnF7/+ and 
A20ZnF4ZnF7/ZnF4ZnF7 mice. (c) Gross appearance of 2-week old A20ZnF4ZnF7/ZnF4ZnF7MyD88-/- mice compared 
to A20ZnF4ZnF7/ZnF4ZnF7MyD88+/-mice. 
 
Extended Data Figure 6. Conditional ‘floxed’ A20ZnF4/ZnF7 knock-in mice. (a) Targeting scheme 
showing the LoxP-flanked (Floxed) and knock-in A20 alleles. Boxes indicate exons 3 to 9 (E3-E9). LoxP 
sites are indicated by arrowheads. (b) Gross appearance of 2 week-old control 
(Tnfaip3ZnF4ZnF7/ZnF4ZnF7CreDel+/+) and Tnfaip3ZnF4ZnF7/ZnF4ZnF7CreDelTg/+ littermate mice. (c) Representative 
histological images of ankle joints from 30-week-old littermate mice with the indicated genotypes. 
Bone erosion was detected by tartrate-resistant acid phosphatase (TRAP) staining of osteoclast 
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activity, and cartilage destruction was assessed by proteoglycan staining with toluidine blue. H/E, 
haematoxylin and eosin. Scale bar: 500 μm. Pictures representative for 5 biologically independent 
mice. (d) Clinical score, based on loss in body weight, stool consistency, and presence of fecal blood, 
of 30 week-old Tnfaip3ZnF4ZnF7/ZnF4ZnF7vilCreTg/+ (n=4) and control (Tnfaip3ZnF4ZnF7/ZnF4ZnF7vilCre+/+, n=4) 
littermate mice treated with 1.5 % DSS. The experiment was stopped at day 5 since 
Tnfaip3ZnF4ZnF7/ZnF4ZnF7vilCreTg/+ started dying. Data are expressed as mean ± SEM. * represents 
p=0.0204 (2-way ANOVA with Sidak’s multiple comparison) (e) Intestinal permeability assay using 
FITC-labelled dextran in 30-week-old Tnfaip3ZnF4ZnF7/ZnF4ZnF7vilCreTg/+ (n=4) and control 
(Tnfaip3ZnF4ZnF7/ZnF4ZnF7vilCre+/+, n=4) mice before and after 5 days of DSS treatment. Data are 
expressed as mean ± SEM. * represents p=0.0143 (2-way ANOVA with Sidak’s multiple comparison) 
a b
c d



















































































Extended Data Figure 4
















































































































































































Extended Data Figure 2
a
Extended Data Figure 1




A20+/+ 25 % (41) 41 41 
A20ZnF7/+ 50 % (83) 82 82 
A20ZnF7/ZnF7 25 % (41) 43 43 
Total (observed) 100 % (166) 166 166 
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